Retinal Progenitor Cell Multipotency via Low Oxygen Culture
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Human retinal progenitor cells have limited proliferative capacity and difficulty integrating into host retinas, limiting their clinical application for treating retinal diseases.
Innovation Solution
Culturing human retinal progenitor cells under low oxygen conditions (1-6% oxygen concentration) enhances their proliferation and maintains their multipotency, allowing for extended passaging and improved differentiation into photoreceptor cells.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If human retinal progenitor cells are cultured under conventional oxygen conditions (20%), then they can be maintained in culture, but their proliferative capacity is limited and they lose multipotency after approximately 7 passages
Solution Approach 1:
The patent applies parameter changes by modifying the oxygen concentration in the culture environment from conventional 20% to physiological levels (1-6%). This environmental parameter change enables human retinal progenitor cells to maintain both high proliferative capacity and multipotency for extended periods (at least 16 passages), resolving the contradiction between productivity and stability of cell properties
2Quantity of substance
If human retinal progenitor cells are passaged multiple times to increase cell numbers, then more cells are available for transplantation, but the cells lose their ability to differentiate into functional photoreceptor cells
Solution Approach 1:
By changing the oxygen parameter to physiological levels (1-6%), the patent enables cells to undergo extensive passaging (at least 16 times) while preserving their differentiation capacity. This resolves the contradiction between increasing cell quantity and maintaining adaptability for differentiation into functional photoreceptors
3Quantity of substance
If the number of passaging cycles is increased to obtain sufficient cells for clinical use, then more cells are available for transplantation, but the integration capability of cells into host retina deteriorates
Solution Approach 1:
The patent uses parameter changes (physiological oxygen levels of 1-6%) to enable extensive cell proliferation through at least 16 passages while maintaining reliable integration capability into host retina. This resolves the contradiction between obtaining sufficient cell quantity and preserving reliability of integration
Data Source
AI summary
The present invention relates to methods for culturing human retinal progenitor cells under low oxygen conditions to allow the cells to retain the ability to differentiate into photoreceptors following transplantation. The described methods provide cells that can treat a number of ocular diseases, including retinitis pigmentosa and age-related macular degeneration.